Immunothérapie d'urgence : antivenins de serpent et de scorpion
Biologie Aujourd'hui, 204 1 (2010) 61-70
Published online: 2010-04-08
Articles citing this article
The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
This article has been cited by the following article(s):
Pathophysiological and therapeutic insights into Viperidae envenomation: Mechanisms, clinical manifestations, and advances in antivenom strategies
Abderrezak KhelfiToxicologie Analytique et Clinique 38 (2) 180 (2026)
https://doi.org/10.1016/j.toxac.2026.01.002
Enhanced production and immuno-toxicological evaluation of chicken egg yolk antibodies (IgY) in laying hens immunized with scorpion venom
Ahlem Seghouani-Baitiche, Amal Megdad-Lamraoui, Sonia Adi-Bessalem, Fares Daachi, Ghania Zitouni and Fatima Laraba-DjebariToxin Reviews 44 (4) 519 (2025)
https://doi.org/10.1080/15569543.2025.2571053
Characterization of Alpha-Bungarotoxin Antibodies Prepared by Different Strategies
Huijuan Lu, Guowen Zhang, Lin Zhao, Ying Yuan, Bing Gong, Bin Han and Wen-Hui LeeToxins 17 (12) 601 (2025)
https://doi.org/10.3390/toxins17120601
Neutralization Capacity of Tissue Alterations Caused by the Venoms of the Most Dangerous Scorpions in North Africa Using a Selective Antivenom
Bouchra Darkaoui, Mohamed Aksim, Ayoub Aarab, Ayoub Lafnoune, Soukaina Khourcha, Rachida Cadi, Ouafaa Aniq Filali and Naoual OukkacheToxins 16 (1) 16 (2023)
https://doi.org/10.3390/toxins16010016
Évaluation de l’efficacité et la tolérance de Inoserp® Panafricain au Sénégal
Absa Lam, Mathilde Cabral, Aminata Touré, et al.Toxicologie Analytique et Clinique 31 (1) 18 (2019)
https://doi.org/10.1016/j.toxac.2018.12.008
Evaluation de la prise en charge des envenimations au Sénégal : étude clinique de l’Inoserp® Panafricain
A. Lam, M. Cabral, A. Touré, et al.Toxicologie Analytique et Clinique 30 (3) 165 (2018)
https://doi.org/10.1016/j.toxac.2018.07.095
La pénurie de sérums antivenimeux
M. GoyffonBulletin de la Société de pathologie exotique 109 (1) 1 (2016)
https://doi.org/10.1007/s13149-016-0470-9
Place de l’immunothérapie dans le traitement actuel des envenimations ophidiennes
Jean-Philippe ChippauxBulletin de l'Académie Nationale de Médecine 197 (4-5) 993 (2013)
https://doi.org/10.1016/S0001-4079(19)31542-0
European viper envenomings: Assessment of Viperfav™ and other symptomatic treatments
David Boels, Jean Francois Hamel, Marie Bretaudeau Deguigne and Patrick HarryClinical Toxicology 50 (3) 189 (2012)
https://doi.org/10.3109/15563650.2012.660695
Epidemiology of snakebites in Europe: A systematic review of the literature
Jean-Philippe ChippauxToxicon 59 (1) 86 (2012)
https://doi.org/10.1016/j.toxicon.2011.10.008
Aspects théoriques et pratiques de l’immunothérapie antivenimeuse en milieu tropical
J.-P. ChippauxArchives de Pédiatrie 18 (5) H160 (2011)
https://doi.org/10.1016/S0929-693X(11)71017-X
Recommandations pour la production, le contrôle et l'enregistrement des immunoglobulines antivenimeuses
Jean-Philippe ChippauxBiologie Aujourd'hui 204 (1) 87 (2010)
https://doi.org/10.1051/jbio/2009043